期刊文献+

白血病细胞可变铁池的检测及其意义 被引量:2

Detection of the Labile Iron Pool in Leukemia Cells and Its Significance
下载PDF
导出
摘要 为了研究细胞可变铁池(labileironpool,LIP)的检测方法,用不同浓度的去铁胺(DFO)与K562及HL-60细胞共同培养0、6、12、24、48小时,用钙荧光素(caicein)负荷K562及HL-60细胞,荧光分辨仪检测细胞荧光量;用快速铁螯合剂螯合铁,使恢复荧光,然后计算2次荧光差值。结果表明:浓度为50和100μmol/L的DFO作用于K562及HL-60细胞12小时后,荧光值明显高于对照组(P<0.05),且LIP的荧光差值(ΔLIP)随DFO作用时间的延长及浓度增加而降低,即呈一定的时间及剂量依赖性。结论:DFO通过螯合细胞内铁降低了白血病细胞LIP;calceinAM荧光可作为检测细胞LIP变化的比较可靠的方法。 To explore a rapid and easy method to detect labile iron of pool (LIP) in cells, HL-60 and K562 cells were cultured at a concentration 1×10^6/ml in RPMI 1640 containing 10% heat- inactivated fetal bovine serum. The iron deprivation was induced by adding de sferrioxamine (DFO) 10 100μmol/L for 0-48 hours. The intracellular LIP was measured by probe calcein-AM. Calcein fluorescence was monitored in 1420 multilabel counter. The results indicated that when HL-60 and K562 cells were incubated with different concentrations of DFO, the calcein fluorescence intensity was higher than that of control group at 12, 24 and 48 hours ( P〈0.05 ). Fluorescence value of representing LIP in DFO groups was lower than that in the control group. In conclusion, DFO can decrease LIP in leukemia cells. The approach used in this study may provide a simple and reliable method for detection of intracellular iron homeostasis.
出处 《中国实验血液学杂志》 CAS CSCD 2006年第3期468-470,共3页 Journal of Experimental Hematology
基金 国家自然基金资助项目(编号:30370601)
关键词 去铁胺 K562 HL-60 iron desferrioxamine K562 HL-60
  • 相关文献

参考文献9

  • 1Richardson DR,Ponka P.The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.Biochim Biophys Acta,1997; 1331:1 -40
  • 2Cabantchik ZI,Glickstein H,Milgram P,et al.A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells.Anal Biochem,1996; 233:221 -227
  • 3Epsztejn S,Kakhlon O,Glickstein H,et al.Fluorescence analysis of the labile iron pool of mammalian cells.Anal Biochem,1997;248:31 -40
  • 4Roy CN,Blemings KP,Deck KM,etal.Increased IRP1 and IRP2RNA binding activity accompanies a reduction of the labile iron pool in HFE-expressing cells.J Cell Physiol,2002; 190:218 -226
  • 5Kakhlon O,Cabantchik ZI.The labile iron pool:characterization,measurement,and participation in cellular processes (1).Free Radic Biol Med,2002; 33:1037-1046
  • 6王强,廖清奎.一氧化氮对慢性病贫血大鼠铁代谢影响[J].中国实验血液学杂志,2003,11(4):385-389. 被引量:6
  • 7Buss JL,Torti FM,Torti SV.The role of iron chelation in cancer therapy.Curr Med Chem,2003; 10:1021-1034
  • 8贾国存,刘玉峰,刘长江.富铁对HL-60细胞增生及化疗药物诱HL-60细胞凋亡的影响[J].中国小儿血液,2001,6(2):58-62. 被引量:3
  • 9Richardson DR.Potential of iron chelators as effective antiproliferative agents.Can J Physiol Pharmacol,1997; 75:1164 -1180

二级参考文献5

共引文献7

同被引文献19

  • 1张秋堂,王叨,刘玉峰.铁对白血病细胞HL-60线粒体膜电位及凋亡的影响[J].实用儿科临床杂志,2006,21(15):998-999. 被引量:5
  • 2汤有才,赵春,贾国存,李丰益,廖清奎,牛文忠,王军.铁剥夺对K562细胞凋亡及细胞周期的影响[J].郑州大学学报(医学版),2006,41(6):1055-1057. 被引量:2
  • 3赵春,李丰益,贾苍松,高举,廖清奎.去铁胺对K562细胞多药耐药基因MDR1及核因子κB表达的影响[J].临床儿科杂志,2007,25(1):47-50. 被引量:2
  • 4张传新,李社军,贾国存,刘玉峰.不同铁状态下HL-60细胞中IRP_2 mRNA的表达[J].肿瘤基础与临床,2007,20(4):299-300. 被引量:1
  • 5Selig RA, White L, Gramacho G, et al. Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts. Cancer Res, 1998; 58(3): 473-478.
  • 6Damell G, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III : the effect of the ligands on molecular targets involved in proliferation. Blood, 1999; 94(2) : 781 -792.
  • 7Rakba N, Loyer P, Gilot D, et al. Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differen- tiated human hepatoma cell lines. Carcinogenesis, 2000; 21 (5) : 943 - 951.
  • 8Gao J, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. IV: The mechanisms involved in inhibiting cell-cycle progression. Blood, 2001 ; 98(3) : 842 -850.
  • 9Lovejoy DB, Richardson DR. Novel "hybrid" iron chelators derived from aroyl-hydrazones and thiosemicarbazones demonstrate selective antipmliferative activity against tumor cells. Blood, 2002 ; 100(2) : 666 -676.
  • 10Le NT, Richardson DR. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21CIP1/ WAF1, but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. Carcinogenesis, 2003 ; 24 ( 6 ), 1045 - 1058.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部